These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10622836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tracking Alzheimer's.
    Roberts L.
    US News World Rep; 1999 Nov 01; 127(17):73. PubMed ID: 10623301
    [No Abstract] [Full Text] [Related]

  • 3. The potential of BACE inhibitors for Alzheimer's therapy.
    Potter H, Dressler D.
    Nat Biotechnol; 2000 Feb 01; 18(2):125-6. PubMed ID: 10657070
    [No Abstract] [Full Text] [Related]

  • 4. Alzheimer's disease. A firm base for drug development.
    De Strooper B, König G.
    Nature; 1999 Dec 02; 402(6761):471-2. PubMed ID: 10591201
    [No Abstract] [Full Text] [Related]

  • 5. Design and development of BACE-1 inhibitors.
    Cumming JN, Iserloh U, Kennedy ME.
    Curr Opin Drug Discov Devel; 2004 Jul 02; 7(4):536-56. PubMed ID: 15338962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
    Dejaegere T, de Strooper B.
    Verh K Acad Geneeskd Belg; 2004 Jul 02; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Drug therapy for aged patients with Alzheimer disease].
    Kudo T.
    Seishin Shinkeigaku Zasshi; 2004 Jul 02; 106(1):62-7. PubMed ID: 15152658
    [No Abstract] [Full Text] [Related]

  • 13. Progress toward a practical BACE-1 inhibitor.
    Hills ID, Vacca JP.
    Curr Opin Drug Discov Devel; 2007 Jul 02; 10(4):383-91. PubMed ID: 17659479
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.
    Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G.
    Ann Neurol; 2002 Jun 02; 51(6):783-6. PubMed ID: 12112088
    [Abstract] [Full Text] [Related]

  • 15. Aryl sulfones: a new class of gamma-secretase inhibitors.
    Teall M, Oakley P, Harrison T, Shaw D, Kay E, Elliott J, Gerhard U, Castro JL, Shearman M, Ball RG, Tsou NN.
    Bioorg Med Chem Lett; 2005 May 16; 15(10):2685-8. PubMed ID: 15863342
    [Abstract] [Full Text] [Related]

  • 16. Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge.
    Citron M.
    Trends Pharmacol Sci; 2004 Feb 16; 25(2):92-7. PubMed ID: 15102495
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
    Vassar R.
    Neuron; 2007 Jun 07; 54(5):671-3. PubMed ID: 17553417
    [Abstract] [Full Text] [Related]

  • 19. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC, Hudson M, Kanning KC, Schecterson LC, Bothwell M.
    J Neurochem; 2005 Sep 07; 94(5):1189-201. PubMed ID: 15992373
    [Abstract] [Full Text] [Related]

  • 20. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.
    Sauder JM, Arthur JW, Dunbrack RL.
    J Mol Biol; 2000 Jul 07; 300(2):241-8. PubMed ID: 10873463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.